Resistant hypertension: evaluation and treatment;Hypertension artérielle résistante : stratification de la prise en charge

Presse Medicale

Volumn 38, Issue 4, 2009, Pages 643-651

  Girerd, Xavier ^a   Rosenbaum, David ^a   Villeneuve, Frédéric ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ARTERIAL PRESSURE; ATHEROMA; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; DOSE RESPONSE; DRUG SUBSTITUTION; ERECTILE DYSFUNCTION; EVALUATION; FIBROUS DYSPLASIA; GYNECOMASTIA; HEREDITARY HYPERTENSION; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; LOW DRUG DOSE; PATIENT COMPLIANCE; SHORT SURVEY; SLEEP APNEA SYNDROME; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 63449108230     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.02.004     Document Type: Short Survey

References (25)

1. Recommandations pour la pratique clinique : prise en charge des patients. adultes atteints d'hypertension artérielle essentielle- Actualisation 2005 http://www.has-sante.fr/portail/jcms/c_272459/prise-en-charge-des-patients-adultes-atteints-dhypertension-arterielle-essentielle-actualisation-2005.
2. Dourmap-Collas C., Girerd X., Begasse F., Marquand A., Asplanato M., Jaboureck O., et al. Comparaison des valeurs de PAS/PAD obtenues lors d'une utilisation séquentielle d'un auto-tensiomètre de bras ou de poignet. Arch Mal Coeur 98 (2005) 774-778
3. Lang T., de Gaudemaris R., Chatellier G., Hamici L., and Diène E. Prevalence and Therapeutic Control of Hypertension in 30 000 Subjects in the Workplace. Hypertension 38 (2001) 449-454
4. Brown M.A., Buddle M.L., and Martin A. Is Resistant Hypertension Really Resistant?. Am J Hypertens 14 (2001) 1263-1269
5. Oikawaa T., Obaraa T., Ohkubob T., Kikuya M., Asayama K., Metoki H., et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements : the J-HOME study. J Hypertens 24 (2006) 1737-1743
6. Garg J.P., Elliott W.J., Folker A., Izhar M., Black H.R., and for the RUSH Hypertension Service. Resistant hypertension revisited: a comparison of 2 university-based cohorts. Am J Hypertens 18 (2005) 619-626
7. Mulazzi I, Cambou JP, Girerd X, Nicodeme R, Chamontin B, Amar J. Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice. Am J Hypertens 2009 (sous presse).
8. Masuo K., Mikami H., Ogihara T., and Tuck M.L. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 32 (1998) 96-100
9. Sowers J.R., Epstein M., and Frolich E.D. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37 (2001) 1053-1059
10. Thijs L., Den Hond E., Nawrot T., and Staessen J.A. Prevalence, pathophysiology and treatment of isolated systolic hypertension in the elderly. Expert Rev Cardiovasc Ther 2 (2004) 761-769
11. Ganguly A. Primary aldosteronism. N Engl J Med 339 (1998) 1828-1834
12. Girerd X., Villeneuve F., Dourmap C., and Baulac C. Prevalence of familial, metabolic and vascular hypertension in treated and untreated subjects. J Hypertension 25 suppl 2 (2007) S370
13. Lloyd-Jones D.M., Evans J.C., Larson M.G., O'Donnell C.J., Rocella E.J., and Levy D. Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension 36 (2000) 594-599
14. Lloyd-Jones D.M., Evans J.C., Larson M.G., and Levy D. Treatment and control of hypertension in the community : a prospective analysis. Hypertension 40 (2002) 640-646
15. Douma S., Petidis K., Doumas M., Papaefthimiou P., Triantafyllou A., Kartali N., et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371 (2008) 1921-1926
16. Calhoun D.A., Jones D., Textor S., Goff D.C., Murphy T.P., Toto R.D., et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117 (2008) e510-e526
17. Sarafidis P.A., and Bakris G.L. Resistant hypertension : an overview of evaluation and treatment. J Am Coll Cardiol 52 (2008) 1749-1757
18. Dickerson J.E., Hingorani A.D., Ashby M.J., Palmer C.R., and Brown M.J. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 353 (1999) 2008-2013
19. Godet-Thobie H., Vernay M., Noukpoape A., Salanave B., Malon A., Castetbon K., et al. Niveau tensionnel moyen et prévalence de l'hypertension artérielle chez les adultes de 18 à 74 ans, ENNS 2006-2007. BEH thématique 49-50 (2008) 478-483
20. Jamerson K., Weber M.A., Bakris G.L., Dahlöf B., Pitt B., Shi V., et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 359 (2008) 2417-2428
21. Neldam S., and Edwards C. Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension. J Clin Hypertens (Greenwich) 10 (2008) 612-618
22. Chrysant S., Melion M., Karki S., Lee J., and Heyrman R. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controller, 8-week factorial efficacy and safety study. Clin Ther 30 (2008) 587-604
23. Chapman N., Dobson J., Wilson S., Dahlöf B., Sever P.S., Wedel H., et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49 (2007) 839-845
24. Saha C., Eckert G.J., Ambrosius W.T., Chun T.Y., Wagner M.A., Zhao Q., et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 46 (2005) 481-487
25. Graves J.W., Bloomfield R.L., and Buckalew Jr. V.M. Plasma volume in resistant hypertension : guide to pathophysiology and therapy. Am J Med Sci 298 (1989) 361-365